Harvard Bioscience, Inc. will release its financial results for the fourth quarter of 2024 on March 12, 2025, before the market opens, and will host a conference call at 8:00 a.m. Eastern Time to ...

HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial ...

Regencell Bioscience is working on TCM opportunities, but what exactly is TCM?

BOULDER , CO, UNITED STATES, February 24, 2026 /EINPresswire.com/ — Mosaic Biosciences, a protein discovery and engineering company enabling the development of next ...

A live video webcast of the event will begin at 1:00 p.m. Eastern Time and can be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcast will be ...

Interim analysis of two-thirds of fully enrolled PRECISION1 trial planned for Q3 2024 Conference call to be held today at 8:30 am EDT LOS ANGELES, Aug. 7, 2024 /PRNewswire/ -- Aadi Bioscience, Inc.

Think Bioscience is reimagining synthetic biology by using living systems to guide the design and assembly of better medicines. The unique approach to drug discovery combines applied microbiology, ...

Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, will host a ...

LITTLETON, Colo. and CHICAGO, June 3, 2025 /PRNewswire/ -- DeFloria, Inc., the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum disorder (ASD), today ...

Earnings call Niagen Bioscience posted Q4 2025 revenue of $33.8M (up 16% YoY) and full-year revenue of $129.4M (up 30% YoY), with net income more than doubling to $17.4M. Management projects 10–15% ...